• About us
• Contact

Advertisement

Organisation › Details

Carlyle (Group)

Carlyle (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across three business segments: Global Private Equity, Global Credit and Investment Solutions. With $260 billion of assets under management as of March 31, 2021, Carlyle’s purpose is to invest wisely and create value on behalf of its investors, portfolio companies and the communities in which we live and invest. Carlyle employs more than 1,800 people in 29 offices across five continents. *

 

	Start	2004-11-22 existent
	Today	Carlyle Group Inc., The (Nasdaq: CG)
	Industry	finance
	Region	Washington, D.C.
	Country	United States (USA)
	Street	1001 Pennsylvania Avenue, NW
	City	20004-2505 Washington, DC
		Address record changed: 2024-01-05
Basic data	Employees	F: 1,001 to 5,000 (2021-07-01)
	Currency	USD
	Annual sales	260,000,000,000 (assets under management (2021) 2021-03-31)
		* Document for »About Section«: Inova Software SAS. (7/1/21). "Press Release: Carlyle Partners with Inova. Growth Equity Transaction to Support Inova’s Ambition to Become the Leading Platform for Life Science Collaborations". Lyon.
		Record changed: 2022-01-18

Advertisement

More documents for Carlyle (Group)

• [1] Abingworth LLP. (10/30/23). "Press Release: Abingworth Raises $356 Million for New Clinical Co-Development Co-Investment Fund (CCD-CIF)". London & New York, NY....
• [2] Carlyle Group, The. (4/11/22). "Press Release: Carlyle Expands Leading Healthcare Franchise with Agreement to Acquire Life Sciences Investment Firm Abingworth". New York, NY....
• [3] Glycomine, Inc.. (12/17/21). "Press Release: Glycomine Closes $68 Million Series B to Advance into Clinical Trials a Novel Treatment for PMM2-CDG, a Rare Glycosylation Disease". San Carlos, CA....
• [4] Anjarium Biosciences AG. (9/16/21). "Press Release: Anjarium Biosciences Raises CHF 55.5M ($61M) Series A Financing to Develop Next-Generation Non-viral Gene Therapies". Schlieren....
• [5] Abingworth LLP. (9/15/21). "Press Release: Abingworth Strengthens Investment Team with New Appointments in the US and UK". London....
• [6] Inova Software SAS. (7/1/21). "Press Release: Carlyle Partners with Inova. Growth Equity Transaction to Support Inova’s Ambition to Become the Leading Platform for Life Science Collaborations". Lyon....
• [7] Abingworth LLP. (5/10/21). "Press Release: Abingworth Raises $582 Million for New Clinical Co-Development Fund – ACCD 2". London....
• [8] Abingworth LLP. (2/3/21). "Press Release: Abingworth Raises $465m for New Life Sciences Fund Abingworth Bioventures 8". London....
• [9] GHO Capital Partners LLP. (6/3/20). "Press Release: GHO Capital Acquires X-Chem, a Leading Drug Discovery Service Provider". London....
• [10] Emulate, Inc.. (3/19/20). "Press Release: Emulate, Inc. Appoints Jim Corbett as Chief Executive Officer and Martin Madaus, PhD, as Executive Chairman". Boston, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.